Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
97.03
+4.17 (+4.50%)
Streaming Delayed Price
Updated: 10:18 AM EST, Nov 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,101,322
Open
94.11
Bid (Size)
97.01 (200)
Ask (Size)
97.06 (500)
Prev. Close
92.86
Today's Range
92.11 - 97.20
52wk Range
73.31 - 105.07
Shares Outstanding
2,531,374,696
Dividend Yield
3.34%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top S&P500 movers in Tuesday's pre-market session
↗
Today 8:35 EST
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year
↗
Today 8:00 EST
Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model.
Via
Investor's Business Daily
Performance
YTD
-2.2%
-2.2%
1 Month
+12.4%
+12.4%
3 Month
+15.2%
+15.2%
6 Month
+25.6%
+25.6%
1 Year
+0.5%
+0.5%
More News
Read More
Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Today 6:45 EST
From
Merck & Co., Inc.
Via
Business Wire
Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover
↗
November 17, 2025
Via
Stocktwits
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring
↗
November 17, 2025
Via
Benzinga
Topics
Artificial Intelligence
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight
↗
November 17, 2025
Via
Benzinga
Topics
ETFs
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
↗
November 17, 2025
Via
Benzinga
MERCK & CO. INC. (NYSE:MRK): A Value Investment with Strong Fundamentals
↗
November 17, 2025
Via
Chartmill
Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation
November 17, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
These 2 Dividend ETFs Are a Retiree's Best Friend
↗
November 16, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
ETFs
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
November 14, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Product Recall
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
November 14, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal
↗
November 14, 2025
Via
Investor's Business Daily
Merck Makes Big Bet On Flu Protection With Cidara Buyout
↗
November 14, 2025
Via
Benzinga
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio
↗
November 14, 2025
Via
Stocktwits
Topics
Intellectual Property
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
November 14, 2025
From
Merck & Co., Inc.
Via
Business Wire
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
↗
November 13, 2025
Via
Stocktwits
Merck to Participate in the Jefferies Global Healthcare Conference in London
November 13, 2025
From
Merck & Co., Inc.
Via
Business Wire
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
November 13, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
↗
November 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?
↗
November 13, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Retirement
The Data Drought of 2024: Recalling the Urgent Call for November Jobs and CPI Figures Post-Shutdown
November 12, 2025
Via
MarketMinute
Topics
Economy
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
November 12, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
November 12, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 97.03
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/18/25 10:18 AM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 245.63B
How many shares of Merck & Co are outstanding?
Merck & Co has 246B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.